Rockwell Medical (RMTI)
(Real Time Quote from BATS)
$1.75 USD
-0.02 (-0.85%)
Updated May 20, 2024 01:53 PM ET
4-Sell of 5 4
B Value C Growth F Momentum C VGM
Brokerage Reports
Rockwell Medical, Inc. [RMTI]
Reports for Purchase
Showing records 201 - 220 ( 240 total )
Company: Rockwell Medical, Inc.
Industry: Medical - Products
Accelerated Launch of Triferic and Calcitriol in China Now Possible
Provider: IFS Securities, Inc.
Analyst: BOUCHEY D
Company: Rockwell Medical, Inc.
Industry: Medical - Products
Update on Calcitriol: October launch appears on track.
Provider: IFS Securities, Inc.
Analyst: BOUCHEY D
Company: Rockwell Medical, Inc.
Industry: Medical - Products
Update on Reimbursement: Is the sun finally ready to shine on Triferic?
Provider: IFS Securities, Inc.
Analyst: BOUCHEY D
Company: Rockwell Medical, Inc.
Industry: Medical - Products
We are initiating coverage of Rockwell Medical with a Strong Buy.
Provider: IFS Securities, Inc.
Analyst: BOUCHEY D
Company: Rockwell Medical, Inc.
Industry: Medical - Products
We are terminating research coverage due to the termination or loss of the primary and/or secondary analysts responsible for coverage.
Provider: DAWSON JAMES SECURITIES, INC.
Company: Rockwell Medical, Inc.
Industry: Medical - Products
Company: Rockwell Medical, Inc.
Industry: Medical - Products
Company: Rockwell Medical, Inc.
Industry: Medical - Products
Company: Rockwell Medical, Inc.
Industry: Medical - Products
We are dropping coverage due to realignment of research coverage since analyst departure
Provider: WEDBUSH SECURITIES INC.
Company: Rockwell Medical, Inc.
Industry: Medical - Products
Reports FY2Q12 Results and Reaffirms Timelines for Upcoming Milestones
Provider: RODMAN & RENSHAW, CO.
Analyst: KING M
Company: Rockwell Medical, Inc.
Industry: Medical - Products
Reports FY2Q12 Results and Reaffirms Timelines for Upcoming Milestones
Provider: RODMAN & RENSHAW, CO.
Analyst: KING M
Company: Rockwell Medical, Inc.
Industry: Medical - Products
CRUISE-1 and CRUISE-2 Fully Enrolled; Updating our Models
Provider: RODMAN & RENSHAW, CO.
Analyst: KING M
Company: Rockwell Medical, Inc.
Industry: Medical - Products
CRUISE-1 and CRUISE-2 Fully Enrolled; Updating our Models
Provider: RODMAN & RENSHAW, CO.
Analyst: KING M
Company: Rockwell Medical, Inc.
Industry: Medical - Products
Troubles for Granuflo May Benefit Rockwells CitraPure
Provider: RODMAN & RENSHAW, CO.
Analyst: KING M
Company: Rockwell Medical, Inc.
Industry: Medical - Products
Troubles for Granuflo May Benefit Rockwells CitraPure
Provider: RODMAN & RENSHAW, CO.
Analyst: KING M
Company: Rockwell Medical, Inc.
Industry: Medical - Products
FY1Q2012 Results In-line with Street Estimates; Focus Remains on Data Catalysts
Provider: RODMAN & RENSHAW, CO.
Analyst: KING M
Company: Rockwell Medical, Inc.
Industry: Medical - Products
FY1Q2012 Results In-line with Street Estimates; Focus Remains on Data Catalysts
Provider: RODMAN & RENSHAW, CO.
Analyst: KING M
Company: Rockwell Medical, Inc.
Industry: Medical - Products
PRIME Phase II Study of SFP Completes Patient Enrollment
Provider: RODMAN & RENSHAW, CO.
Analyst: KING M
Company: Rockwell Medical, Inc.
Industry: Medical - Products
PRIME Phase II Study of SFP Completes Patient Enrollment
Provider: RODMAN & RENSHAW, CO.
Analyst: KING M
Company: Rockwell Medical, Inc.
Industry: Medical - Products
Initiating Coverage with a Market Outperform Rating; $16 Price Target
Provider: RODMAN & RENSHAW, CO.
Analyst: KING M